aPad
aPad - smaller, lighter, smarter autonomous marine surface vehicle
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0aPad project word cloud
Explore the words cloud of the aPad project. It provides you a very rough idea of what is the project "aPad" about.
Project "aPad" data sheet
The following table provides information about the project.
| Coordinator |
SVEUCILISTE U ZAGREBU FAKULTET ELEKTROTEHNIKE I RACUNARSTVA
Organization address contact info |
| Coordinator Country | Croatia [HR] |
| Project website | https://labust.fer.hr/zari/labust/research/projects/ongoing_projects/apad |
| Total cost | 99˙750 € |
| EC max contribution | 99˙750 € (100%) |
| Programme |
1. H2020-EU.1.2.1. (FET Open) |
| Code Call | H2020-FETOPEN-4-2016-2017 |
| Funding Scheme | CSA |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-05-01 to 2018-10-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | SVEUCILISTE U ZAGREBU FAKULTET ELEKTROTEHNIKE I RACUNARSTVA | HR (ZAGREB) | coordinator | 99˙750.00 |
Map
Project objective
'The project proposes transformation of Autonomous Unmanned Marine Surface vehicle 'aPad', the specific research result of the ongoing FET project no. 640967 'subCULTron', into commercially attractive, sustainable and innovative product that both address societal challenges and is highly competitive in global markets. Our initial market research, end-users inquiries and even first acquisition suggest high market potential of the aPad. Furthermore, Autonomous Unmanned Vehicles are at the top of Emerging Technologies reports. Associating these with the fact that 70% of our planet is covered by the sea give us solid motivation for this proposal. Current stage of aPad development, according to EC Technology Readiness Level scale, is 6 (prototype demonstration in a relevant environment). The project foresees three main groups of activities. The first is development of a business plan to support future commercialization process, including strong brand development based on market analysis and development of strategies for three main pillars of innovation business: market, intellectual property and finances. The second is oriented towards linking and interacting with the identified potential customers, societal end-users and investors to collect their feedback, assess technological impact on the society, develop case studies and detect potential future partners. The third one is preparation for the actual spin-off oriented towards establishment of the manufacturing processes and building of spin-off organizational structure. UNIZG-FER Croatia positioned itself as the regional leader in robotics, coordinating and participating in number of research and industry projects. Two UNIZG-FER entities will participate in the project: Laboratory for Underwater Systems and Technologies (LABUST) actual developer of the aPad, will lead all project activates while Research Support Centre (CePI) will participate in development of the business plan and exploration of an exploitation path.'
Deliverables
| Spin-off company | Other | 2019-05-15 13:58:00 |
Take a look to the deliverables list in detail: detailed list of aPad deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "APAD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "APAD" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.1.2.1.)
PANACHE (2020)
Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.
Read More